Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma

Autologous hematopoietic stem cell transplantation (AuHSCT) is standard in treating eligible multiple myeloma (MM) patients. However, the outcome after treatment is highly variable. We used ELISA to analyze the levels of soluble PD-L1 (suPD-L1) in bone marrow (BM) plasma from 61 patients with MM at...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Huang, Shang-Yi, Lin, Hsiu-Hsia, Lin, Chung-Wu, Li, Chi-Cheng, Yao, Ming, Tang, Jih-Luh, Hou, Hsin-An, Tsay, Woei, Chou, Sheng-Je, Cheng, Chieh-Lung, Tien, Hwei-Fang
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5308741/
https://ncbi.nlm.nih.gov/pubmed/27566569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11519
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados